A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Hemophilia & Sickle Cell Bookmark and Share

Hemophilia and Sickle Cell Program

The Hemophilia and Sickle Cell Program at City of Hope provides care to children, adolescents and young adults (AYA) with inherited coagulation disorders, such as hemophilia and red blood cell disorders like sickle cell anemia. We are a regional referral center for these disorders and provide support to hospitals and physicians locally, nationally and internationally.

Our hemophilia and sickle cell program has earned Center of Excellence designations from California Children’s Services, and we are one of approximately 145 federally funded comprehensive Hemophilia Treatment Centers (HTCs) in the U.S. We bring together a multidisciplinary team of doctors, nurses and other health professionals experienced in treating children with inherited coagulation disorders and red blood cell disorders. We provide comprehensive care for infants, children, adolescents and young adults with:
 
  • Hemophilia and Von Willebrand disease
  • Platelet abnormalities, including idiopathic thrombocytopenic purpura (ITP), other thrombocytopenias and platelet dysfunction
  • Disorders of hemostasis and thrombosis
  • Red blood cell abnormalities, including sickle cell anemia and iron deficiency
  • Non-malignant hematologic disorders
  • Bone marrow and neutrophil disorders, including aplastic anemia, storage diseases and neutropenia
     
For patients with hemophilia and other inherited coagulation disorders, we provide consultations to hematologists and oncologists, pediatricians, pediatric surgeons, dentists and ob/gyns. Our areas of expertise include:
 
  • Inhibitors in hemophilia A and B
  • Risk factors for and prevention of inhibitor formation
  • Early diagnosis of inhibitors
  • Treatment of bleeding in patients with inhibitors
  • Prophylaxis to prevent bleeding and preserve joint health
  • Inhibitor eradication using Immune Tolerance Induction (ITI)
     
For patients with sickle cell disease and other red blood cell disorders, our emphasis is on preventing disease-related and treatment-related complications. We work to ensure that pain is adequately managed so that patients can maintain a good quality of life. We also work closely with the City of Hope Hematopoietic Cell Transplantation Program.
 
Given the hereditary nature of these conditions, we offer genetic testing, including carrier testing and counseling. We meet with the family after diagnosis to discuss the chances of having other children with a blood disorder, and we educate children in an age-appropriate manner.

Our program offers both medical treatment and psychosocial support to young patients and their family members. Our medical team collaborates to develop an effective, individualized treatment plan, while professionals in nursing; psychology; social work; physical, occupational and recreational therapy; and school re-integration provide individual attention and group activities for patients and their families.
 
The pediatric comprehensive care team for the hemophilia and the sickle cell programs includes:

Our physicians and scientists are leading research to find better treatments for patients with inherited blood disorders. For more information on our pediatric hematology research, including ongoing clinical trials, visit City of Hope’s Clinical Trials Online website.
 

Hemophilia & Sickle Cell

Hemophilia and Sickle Cell Program

The Hemophilia and Sickle Cell Program at City of Hope provides care to children, adolescents and young adults (AYA) with inherited coagulation disorders, such as hemophilia and red blood cell disorders like sickle cell anemia. We are a regional referral center for these disorders and provide support to hospitals and physicians locally, nationally and internationally.

Our hemophilia and sickle cell program has earned Center of Excellence designations from California Children’s Services, and we are one of approximately 145 federally funded comprehensive Hemophilia Treatment Centers (HTCs) in the U.S. We bring together a multidisciplinary team of doctors, nurses and other health professionals experienced in treating children with inherited coagulation disorders and red blood cell disorders. We provide comprehensive care for infants, children, adolescents and young adults with:
 
  • Hemophilia and Von Willebrand disease
  • Platelet abnormalities, including idiopathic thrombocytopenic purpura (ITP), other thrombocytopenias and platelet dysfunction
  • Disorders of hemostasis and thrombosis
  • Red blood cell abnormalities, including sickle cell anemia and iron deficiency
  • Non-malignant hematologic disorders
  • Bone marrow and neutrophil disorders, including aplastic anemia, storage diseases and neutropenia
     
For patients with hemophilia and other inherited coagulation disorders, we provide consultations to hematologists and oncologists, pediatricians, pediatric surgeons, dentists and ob/gyns. Our areas of expertise include:
 
  • Inhibitors in hemophilia A and B
  • Risk factors for and prevention of inhibitor formation
  • Early diagnosis of inhibitors
  • Treatment of bleeding in patients with inhibitors
  • Prophylaxis to prevent bleeding and preserve joint health
  • Inhibitor eradication using Immune Tolerance Induction (ITI)
     
For patients with sickle cell disease and other red blood cell disorders, our emphasis is on preventing disease-related and treatment-related complications. We work to ensure that pain is adequately managed so that patients can maintain a good quality of life. We also work closely with the City of Hope Hematopoietic Cell Transplantation Program.
 
Given the hereditary nature of these conditions, we offer genetic testing, including carrier testing and counseling. We meet with the family after diagnosis to discuss the chances of having other children with a blood disorder, and we educate children in an age-appropriate manner.

Our program offers both medical treatment and psychosocial support to young patients and their family members. Our medical team collaborates to develop an effective, individualized treatment plan, while professionals in nursing; psychology; social work; physical, occupational and recreational therapy; and school re-integration provide individual attention and group activities for patients and their families.
 
The pediatric comprehensive care team for the hemophilia and the sickle cell programs includes:

Our physicians and scientists are leading research to find better treatments for patients with inherited blood disorders. For more information on our pediatric hematology research, including ongoing clinical trials, visit City of Hope’s Clinical Trials Online website.
 
Patient Care Overview

City of Hope Locations

Patient Stories and Videos

Meet City of Hope patients and their families.
 
 
Clinics/Treatments/Services
As a Comprehensive Cancer Center – the highest designation given by the National Cancer Institute – we are widely regarded as a leader in cancer prevention and treatment.

Cancer Expertise Matters


NEWS & UPDATES
  • Equipping the immune system to fight cancer – a disease that thrives on mutations and circumventing the body’s natural defenses – is within reach. In fact, City of Hope researchers are testing one approach in clinical trials now. Scientists take a number of steps to turn cancer patients’ T cells – white b...
  • As treatments for lung cancer become more targeted and effective, the need for better technology to detect lung cancer mutations becomes increasingly important. A new clinical study at City of Hope is examining the feasibility of using blood and urine tests to detect lung cancer mutations, potentially allowing ...
  • When it comes to breast cancer risk, insulin levels may matter more than weight, new research has found. The study from Imperial College London School of Public Health, published in the journal Cancer Research, indicates that metabolic health – not a person’s weight or body mass index – increases breast cancer ...
  • No one ever plans to have cancer – and there’s never a good time. For Homa Sadat, her cancer came at a particularly bad time: just one year after losing her father to the pancreatic cancer he had battled for two years. She was working a grueling schedule managing three commercial office buildings. She’d just [&...
  • Patients at City of Hope – most of whom are fighting cancer – rely on more than 37,000 units of blood and platelets each year for their treatment and survival. Every one of those units comes from family, friends or someone who traded an hour or so of their time and a pint of their […]
  • Surgery is vital in the treatment of cancer – it’s used to help diagnose, treat and even prevent the disease – so a new colorectal cancer study linking a decrease in surgeries for advanced cancer to increased survival rates may raise more questions than it answers for some patients. The surgery-and-surviv...
  • Age is the single greatest risk factor overall for cancer; our chances of developing the disease rise steeply after age 50. For geriatric oncology nurse Peggy Burhenn, the meaning is clear: Cancer is primarily a geriatric condition. That’s why she is forging inroads in the care of older adults with cancer. Burh...
  • One of American’s great sportscasters, Stuart Scott, passed away from recurrent cancer of the appendix at the young age of 49. His cancer was diagnosed when he was only 40 years old. It was found during an operation for appendicitis. His courageous fight against this disease began in 2007, resumed again with an...
  • When Homa Sadat found a lump in her breast at age 27, her gynecologist told her what many doctors say to young women: You’re too young to have breast cancer. With the lump dismissed as a harmless cyst, she didn’t think about it again until she was at a restaurant six months later and felt […]
  • What most people call a “bone marrow transplant” is not actually a transplant of bone marrow; it is instead the transplantation of what’s known as hematopoietic stem cells. Such cells are often taken from bone marrow, but not always. Hematopoietic stem cells are simply immature cells that can ...
  • Doctors have long known that women with a precancerous condition called atypical hyperplasia have an elevated risk of breast cancer. Now a new study has found that the risk is more serious than previously thought. Hyperplasia itself is an overgrowth of cells; atypical hyperplasia is an overgrowth in a distorted...
  • Don’t kid yourself. Just because it’s mid-January doesn’t mean it’s too late to make resolutions for a happier, and healthier, 2015. Just consider them resolutions that are more mature than those giddy, sometimes self-deluded, Jan. 1 resolutions. To that end, we share some advice from Cary A. Presant, M.D., an ...
  • Sales and marketing executive Jim Murphy first came to City of Hope in 2002 to donate blood for a friend who was being treated for esophageal cancer. The disease is serious. Although esophageal cancer accounts for only about 1 percent of cancer diagnoses in the U.S., only about 20 percent of patients survive at...
  • Aaron Bomar and his family were celebrating his daughter’s 33rd birthday in September 2014 when he received alarming news: According to an X-ray taken earlier that day at an urgent care facility, he had a node on his aorta and was in danger of an aneurysm. Bomar held hands with his wife and daughter and s...
  • Explaining a prostate cancer diagnosis to a young child can be difficult — especially when the cancer is incurable. But conveying the need for prostate cancer research, as it turns out, is easily done. And that leads to action. Earlier this year, Gerald Rustad, 71, who is living with a very aggressive form of m...